Yelena Janjigian
Jun 3, 2025, 08:32
Memorial Sloan Kettering Cancer Center – New Hope for People with Stomach and Esophagus Cancer
Memorial Sloan Kettering Cancer Center posted on X:
“New research from ASCO: A clinical trial led by Yelena Janjigian, Chief of Gastrointestinal Medical Oncology at MSK, has demonstrated a powerful new approach to help prevent cancer from coming back after treatment for stomach cancer and cancer of the lower portion of the esophagus and gastroesophageal junction (GEJ).
“For gastroesophageal cancer patients to go through surgery and chemo, it’s devastating to have a recurrence of the cancer,” says Dr. Janjigian. “This trial shows that adding immunotherapy to chemo before and after surgery can dramatically improve the chance that cancer won’t return.”
Learn more about how these results offer new hope to people facing this diagnosis, which is the fifth most common cancer worldwide.”
More posts featuring ASCO25.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 3, 2025, 10:55
Jul 3, 2025, 10:25
Jul 3, 2025, 10:24
Jul 3, 2025, 10:16
Jul 3, 2025, 10:15
Jul 3, 2025, 10:04